Makoto Inoue: Influence Statistics

Makoto Inoue

Makoto Inoue

Department of Ophthalmology, Kyorin University School of Medicine, Tokyo, Japan | Department of Ophthalmology, Kyorin University, Tokyo, Japan | Kyorin Eye Center, Kyorin ...

Makoto Inoue: Expert Impact

Concepts for which Makoto Inoue has direct influence: Macular hole , Retinal detachment , Model eye , Intraocular lenses , Blood flow , Macular detachment , Vitreous surgery .

Makoto Inoue: KOL impact

Concepts related to the work of other authors for which for which Makoto Inoue has influence: Diabetic retinopathy , Visual acuity , Retinal detachment , Macular hole , Optical coherence , Triamcinolone acetonide , Plana vitrectomy .

KOL Resume for Makoto Inoue

Year
2022

Department of Ophthalmology, Kyorin University School of Medicine, Tokyo, Japan

2021

Department of Ophthalmology, Kyorin University, Tokyo, Japan

2020

Kyorin Eye Center, Kyorin University School of Medicine, Tokyo, Japan.

2019

Kyorin Eye Center, Kyorin University School of Medicine, 6-20-2 Shinkawa, 181-8611, Mitaka, Tokyo, Japan

2018

From the Department of Ophthalmology (Seo, Nam, Lee, Park, Y.J. Kim), Gachon University Gil Hospital, Incheon, the Department of Ophthalmology (S.-W. Kim), Korea University College of Medicine, and the Department of Ophthalmology (Chung), Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea; the Kyorin Eye Center (Inoue), Kyorin University School of Medicine, Mitaka, Tokyo, Japan; the Department of Ophthalmology (T. Kim), Duke University Eye Center, Durham, North Carolina, USA

Kyorin Eye Center, Department of Ophthalmology, Kyorin University School of Medicine, Tokyo, Japan.

2017

Department of Ophthalmology, Kyorin University School of Medicine, 6-20-2 Shinkawa, 181-8611, Mitaka, Tokyo, Japan

2016

Department of Ophthalmology, Kyorin University School of Medicine, 6-20-2 Shinkawa, Mitaka, 181-8611, Tokyo, Japan

2015

Kyorin Eye Center, Kyorin University School of Medicine, Tokyo - Japan

2014

Kryorin Eye Center, Kryorin University School of Medicine, 6-20-2 Shinkawa, 181-8611, Mitaka, Tokyo, Japan

2013

Kyorin Eye Center Kyorin University School of Medicine TokyoJapan

Departemnt of Ophthalmology, Keio University School of Medicine, Tokyo, Japan

2012

Department of Ophthalmology, Kyorin University School of Medicine, Tokyo, Japan.

Kyorin Eye Center, Kyorin University School of Medicine, Mitaka, Tokyo, Japan

2011

Kyorin Eye Center, Kyorin University School of Medicine, Mitaka, Japan

2010

Kyorin Eye Center, Kyorin University School of Medicine, Tokyo 181-8611, Japan

Department of Ophthalmology, Keio University School of Medicine

2009

Department of Ophthalmology, Keio University School of Medicine, Kyorin Eye Center, Kyorin University School of Medicine, Tokyo, Department of Ophthalmology, Teikyo University Faculty of Medicine, Oita, Japan

2008

From the Department of Ophthalmology, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan.

Kyorin Eye Center, Kryorin University, Tokyo, Japan

2007

Kyorin Eye Center, Kyorin University School of Medicine, Tokyo, and

From the Department of Ophthalmology, Keio University School of Medicine, Tokyo, Japan.

Department of Ophthalmology, Keio University School of Medicine, Keio University School of Medicine, Tokyo, Japan

2006

From the Departments of Ophthalmology,

2005

Department of Ophthalmology, Keio University of School of Medicine, 35 Shinanomachi, Shinjyuku-ku, 160-8582, Tokyo, Japan

2004

Department of Ophthalmology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan.

2003

Ophthalmology, Keio University School of Medicine, and

2002

*Department of Ophthalmology, Keio University School of Medicine, and the †Department of Pathology, Saiseikai Central Hospital, Tokyo, Japan.

2001

Department of Ophthalmology, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan

2000

Keio University School of Medicine, Tokyo, Japan

1996

Department of Ophthalmology, Keio University School of Medicine, Shinjuku-ku, Japan

1995

Department of Ophthalmology, Keio University School of Medicine, Tokyo, Japan.

Prominent publications by Makoto Inoue

KOL-Index: 19621 . PURPOSE: To determine whether the postoperative length of the photoreceptor cone outer segment tips (COST) line defect is significantly correlated with best-corrected visual acuity (BCVA) after macular hole closure. DESIGN: Retrospective, consecutive, observational case series. PARTICIPANTS: Fifty-one eyes of 51 patients with a surgically closed macular hole were studied. METHODS: ...
Known for Cost Defect | Macular Hole | Outer Segment | Visual Acuity
KOL-Index: 18755 . PURPOSE: To investigate the retinal neural damage that occurs during inflammation and the therapeutic effects of the angiotensin II type 1 receptor (AT1R) blocker, telmisartan, using a model of endotoxin-induced uveitis (EIU). METHODS: The localization of AT1R and AT2R was shown by immunohistochemistry. EIU was induced by intraperitoneal injection of lipopolysaccharide (LPS). Animals were ...
Known for Retinal Inflammation | Type 1 | Neuroprotective Effects | Treatment Telmisartan
KOL-Index: 18524 . PURPOSE: To investigate the involvement of the renin-angiotensin system (RAS) and the nuclear factor (NF)-kappaB pathway with diabetes-induced retinal inflammation. METHODS: Six weeks after induction of diabetes, C57BL/6 mice were treated with the angiotensin II type 1 receptor (AT1-R) blocker (ARB) telmisartan or valsartan, the AT2-R blocker PD123319, or the NF-kappaB inhibitor ...
Known for Type 1 | Nuclear Factor | Induced Retinal | Messenger Receptor
KOL-Index: 16057 . PURPOSE: To evaluate the clinical outcomes after vitrectomy, without gas tamponade or laser photocoagulation to the margin of the optic nerve, for the treatment of macular detachment associated with optic disc pits and to characterize retinal manifestations during treatment of optic pit maculopathy using optical coherence tomography (OCT). DESIGN: Noncomparative, retrospective, ...
Known for Macular Detachment | Gas Tamponade | Optic Disc Pit | Laser Treatment
KOL-Index: 15380 . PURPOSE: To examine whether the angiotensin II type 1 receptor (AT1-R) signaling plays a role in ocular inflammation in endotoxin-induced uveitis (EIU). METHODS: EIU was induced in C57BL/6 mice by a single intraperitoneal injection of 150 mug lipopolysaccharide (LPS). Tissue localization, mRNA expression, and protein levels of AT1-R in murine retinas were examined by immunohistochemistry, ...
Known for Ocular Inflammation | Type 1 | Induced Uveitis | Leukocyte Adhesion
KOL-Index: 15024 . PURPOSE: A recent study revealed that angiotensin receptor signaling mediates ocular inflammation and neovascularization. It was also found that prorenin undergoes nonproteolytic activation leading to upregulation of the renin-angiotensin system (RAS) when prorenin receptor interacts specifically with the handle region of prorenin. The purpose of the present study was to elucidate the role ...
Known for Ocular Inflammation | Prorenin Receptor | Nonproteolytic Activation | Induced Uveitis
KOL-Index: 14600 . PURPOSE: To determine whether a recovery of the microstructures of the foveal photoreceptors after macular hole closure is correlated with best-corrected visual acuity (BCVA). DESIGN: Retrospective, consecutive, observational case series. METHODS: SETTING: Single-center academic practice. STUDY POPULATION: Forty-one eyes of 41 patients with surgically closed macular holes. OBSERVATIONAL ...
Known for Visual Acuity | Macular Hole Surgery | Foveal Cone | Eyes Bcva
KOL-Index: 14452 . PURPOSE: Angiotensin-converting enzyme (ACE), also known as kininase II, functions not only to convert angiotensin I to angiotensin II, but also to cleave bradykinin into inactive fragments. Thus, ACE inhibition causes the tissue accumulation of bradykinin, exerting either of two opposite effects: anti- or proangiogenic. The purpose of the present study was to investigate the role of ...
Known for Choroidal Neovascularization | Converting Enzyme | Cnv Vegf | Receptor Angiotensin
KOL-Index: 13919 . BACKGROUND: To determine whether the status of a macular hole can be determined by spectral-domain optical coherence tomography in gas-filled eyes. DESIGN: Prospective study, university hospital setting. PARTICIPANTS: Twenty-six eyes with a macular hole, seven eyes with a macular hole retinal detachment and four eyes with a macular hole and myopic traction maculopathy underwent vitreous ...
Known for Macular Hole | Optical Coherence | Eyes Day | Postoperative Status
KOL-Index: 13754 . PURPOSE: To investigate the structural abnormalities of optic disc pits and colobomas by swept-source optical coherence tomography (OCT). METHODS: Sixteen eyes with congenital optic disc pits, and seven eyes with optic disc colobomas were studied. Papillary and peripapillary areas were examined with swept-source OCT. The entire course of the pit or cavity and the spatial relationship ...
Known for Optic Disc | Coherence Tomography | Source Oct | Lamina Cribrosa
KOL-Index: 13473 . PURPOSE: To determine whether there is a significant correlation between the integrity of the foveal microstructures and the best-corrected visual acuity (BCVA) after pars plana vitrectomy for epiretinal membrane (ERM) removal. METHODS: This was a retrospective, interventional case series. Forty-six eyes of 45 patients with an ERM underwent vitrectomy. The foveal area was examined by ...
Known for Epiretinal Membrane | Outer Segment | Bcva Length | Cost Defect
KOL-Index: 13162 . Interleukin (IL)-6, a potent proinflammatory cytokine, is suggested to be a risk factor for choroidal neovascularization (CNV) because of its increased levels in the serum of patients with age-related macular degeneration; however, the role of IL-6 in CNV has not been defined. The present study reveals the critical contribution of IL-6 signaling and its downstream STAT3 pathway to the ...
Known for Choroidal Neovascularization | Il6 Cnv | Signal Transducer | Agerelated Macular Degeneration
KOL-Index: 13041 . PURPOSE: To investigate the anti-inflammatory and anti-angiogenic effects of telmisartan, an angiotensin II type 1 receptor (AT1-R) antagonist, on ischemia-induced retinal neovascularization. METHODS: C57BL/6 neonatal mice were reared in an 80% concentration of oxygen from postnatal day (P)7 to P12, followed by room-air breathing until P17, to induce ischemia-initiated retinal ...
Known for Type 1 | Retinal Neovascularization | Messenger Receptor | Physiologic Rna
KOL-Index: 12691 . PURPOSE: To investigate the matrix metalloproteinase (MMP) species and their activation associated with the pathogenesis of proliferative diabetic retinopathy (PDR). METHODS: Sandwich enzyme immunoassays were used to measure concentrations of MMP-1, -2, -3, -7, -8, -9, and -13 in vitreous samples from patients with PDR and nondiabetic vitreoretinal diseases. To evaluate activation ratios ...
Known for Matrix Metalloproteinase | Fibrovascular Tissues | Vitreous Samples | Mmp2 Mt1mmp
KOL-Index: 12295 . PURPOSE: To evaluate the effect of vitrectomy on the best-corrected visual acuity (BCVA) and postoperative complications in highly myopic eyes with myopic traction maculopathy. METHODS: The medical records of 71 eyes of 64 patients with myopic traction maculopathy and high myopia (≤-8.0 diopters and axial length, ≥26.0 mm) were reviewed. Twenty-six eyes had only macular retinoschisis, 30 ...
Known for Myopic Traction | Membrane Peeling | Macular Retinoschisis | Foveal Detachment

Key People For Macular Hole

Top KOLs in the world
#1
William E Smiddy
visual acuity macular hole retinal detachment
#2
Alain Gaudric
macular edema optical coherence diabetic retinopathy
#3
Robert T Wendel
pneumatic retinopexy macular hole cilioretinal artery
#4
J Donald M Gass
visual acuity macular holes fluorescein angiography
#5
Neil E Kelly
pneumatic retinopexy macular holes vitreous surgery
#6
Pascale Massin
diabetic retinopathy macular edema visual acuity

Department of Ophthalmology, Kyorin University School of Medicine, Tokyo, Japan | Department of Ophthalmology, Kyorin University, Tokyo, Japan | Kyorin Eye Center, Kyorin University School of Medicine, 6-20-2 Shinkawa, Mitaka, 181-8611, Tokyo, Japan